Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Tuesday 4th August 2020
Share Talk Bulletin Board Heroes, Wednesday 22nd July 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Tuesday 19th May 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Share Talk Bulletin Board Heroes, Thursday 16th April 2020
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Exclusive to Share Talk, here
Share Talk Bulletin Board Heroes, Thursday 31st October 2019
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.
Share Talk Bulletin Board Heroes, Tuesday 29th October 2019
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.
Share Talk Bulletin Board Heroes, Friday 18th October 2019
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update.
Oxford BioDynamics (AIM:OBD) presents at the Diabetes Asia 2017 Conference
EpiSwitch™ successful in stratifying patients into different stages of type 2 diabetes Oxford BioDynamics Plc (“OBD” or the “Company”), a biotechnology company focused on the discovery and development of epigenetic biomarkers
TheBizLounge: Oxford Biodynamics’ half year, plus billionaire neighbours from hell!
Taking the stress out of stocks… New AIM listed biotech firm Oxford Biodynamics reported first set of results as listed company today. After the period end, though it signed up
